Stromal depletion by TALEN-edited universal hypoimmunogenic FAP-CAR T cells enables infiltration and anti-tumor cytotoxicity of tumor antigen-targeted CAR-T immunotherapy
Adoptive cell therapy based on chimeric antigen receptor (CAR)-engineered T-cells has proven to be lifesaving for many cancer patients. However, its therapeutic efficacy has so far been restricted to only a few malignancies, with solid tumors proving to be especially recalcitrant to efficient therap...
Main Authors: | Shipra Das, Julien Valton, Philippe Duchateau, Laurent Poirot |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-05-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1172681/full |
Similar Items
-
TALENs—an indispensable tool in the era of CRISPR: a mini review
by: Anuradha Bhardwaj, et al.
Published: (2021-08-01) -
Fine and Predictable Tuning of TALEN Gene Editing Targeting for Improved T Cell Adoptive Immunotherapy
by: Anne-Sophie Gautron, et al.
Published: (2017-12-01) -
Overcoming tumor resistance mechanisms in CAR-NK cell therapy
by: Antonio Valeri, et al.
Published: (2022-08-01) -
Plant genome editing with TALEN and CRISPR
by: Aimee Malzahn, et al.
Published: (2017-04-01) -
CAR-armored-cell therapy in solid tumor treatment
by: Yan Liu, et al.
Published: (2024-11-01)